These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 16733631)

  • 1. Family support predicts psychiatric medication usage among Mexican American individuals with schizophrenia.
    Ramírez García JI; Chang CL; Young JS; López SR; Jenkins JH
    Soc Psychiatry Psychiatr Epidemiol; 2006 Aug; 41(8):624-31. PubMed ID: 16733631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expressed emotion and health outcomes among Mexican-Americans with schizophrenia and their caregiving relatives.
    Breitborde NJ; López SR; Kopelowicz A
    J Nerv Ment Dis; 2010 Feb; 198(2):105-9. PubMed ID: 20145484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ability of multifamily groups to improve treatment adherence in Mexican Americans with schizophrenia.
    Kopelowicz A; Zarate R; Wallace CJ; Liberman RP; Lopez SR; Mintz J
    Arch Gen Psychiatry; 2012 Mar; 69(3):265-73. PubMed ID: 22393219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emotional over-involvement can be deleterious for caregivers' health: Mexican Americans caring for a relative with schizophrenia.
    Breitborde NJ; López SR; Chang C; Kopelowicz A; Zarate R
    Soc Psychiatry Psychiatr Epidemiol; 2009 Sep; 44(9):716-23. PubMed ID: 19190836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Family caregivers' monitoring of medication usage: a qualitative study of Mexican-origin families with serious mental illness.
    Marquez JA; Ramírez García JI
    Cult Med Psychiatry; 2011 Mar; 35(1):63-82. PubMed ID: 21153047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of atypical antipsychotics for substance use in schizophrenia patients.
    Swanson J; Van Dorn RA; Swartz MS
    Schizophr Res; 2007 Aug; 94(1-3):114-8. PubMed ID: 17587548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using the theory of planned behavior to improve treatment adherence in Mexican Americans with schizophrenia.
    Kopelowicz A; Zarate R; Wallace CJ; Liberman RP; Lopez SR; Mintz J
    J Consult Clin Psychol; 2015 Oct; 83(5):985-93. PubMed ID: 26030760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlates of prescription and over-the-counter medication usage among older Mexican Americans: the Hispanic EPESE study. Established Population for the Epidemiologic Study of the Elderly.
    Espino DV; Lichtenstein MJ; Hazuda HP; Fabrizio D; Wood RC; Goodwin J; Stroup-Benham CA; Markides KS
    J Am Geriatr Soc; 1998 Oct; 46(10):1228-34. PubMed ID: 9777904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medication adherence and long-term functional outcomes in the treatment of schizophrenia in usual care.
    Ascher-Svanum H; Faries DE; Zhu B; Ernst FR; Swartz MS; Swanson JW
    J Clin Psychiatry; 2006 Mar; 67(3):453-60. PubMed ID: 16649833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of the measurement of medication administration hassles with Mexican American family caregivers.
    Kao HF; Lynn MR
    J Clin Nurs; 2009 Sep; 18(18):2596-603. PubMed ID: 19538565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective evaluation of adherence to medication in first episode schizophrenia.
    Kamali M; Kelly BD; Clarke M; Browne S; Gervin M; Kinsella A; Lane A; Larkin C; O'Callaghan E
    Eur Psychiatry; 2006 Jan; 21(1):29-33. PubMed ID: 16460918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early predictors of nonadherence to antipsychotic therapy in first-episode psychosis.
    Rabinovitch M; Béchard-Evans L; Schmitz N; Joober R; Malla A
    Can J Psychiatry; 2009 Jan; 54(1):28-35. PubMed ID: 19175977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting medication noncompliance after hospital discharge among patients with schizophrenia.
    Olfson M; Mechanic D; Hansell S; Boyer CA; Walkup J; Weiden PJ
    Psychiatr Serv; 2000 Feb; 51(2):216-22. PubMed ID: 10655006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Symptoms, functioning and coping strategies in individuals with schizophrenia spectrum disorders who do not take antipsychotic medication: a comparative interview study.
    Jung E; Wiesjahn M; Wendt H; Bock T; Rief W; Lincoln TM
    Psychol Med; 2016 Jul; 46(10):2179-88. PubMed ID: 27269768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A peer support programme for enhancing adherence to oral antipsychotic medication in consumers with schizophrenia.
    Boardman G; McCann T; Kerr D
    J Adv Nurs; 2014 Oct; 70(10):2293-302. PubMed ID: 24628395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of ethnicity in predicting antipsychotic medication adherence.
    Opolka JL; Rascati KL; Brown CM; Gibson PJ
    Ann Pharmacother; 2003 May; 37(5):625-30. PubMed ID: 12708934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expressed emotion and family interactions in Mexican Americans with schizophrenia.
    Kopelowicz A; López SR; Zarate R; O'Brien M; Gordon J; Chang C; Gonzalez-Smith V
    J Nerv Ment Dis; 2006 May; 194(5):330-4. PubMed ID: 16699381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Relationships between insight and medication adherence in subjects with psychosis].
    Droulout T; Liraud F; Verdoux H
    Encephale; 2003; 29(5):430-7. PubMed ID: 14615692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment adherence and insight in schizophrenia.
    Bitter I; Fehér L; Tényi T; Czobor P
    Psychiatr Hung; 2015; 30(1):18-26. PubMed ID: 25867885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adherence to antipsychotic drug treatment in early-episode schizophrenia: a six-month naturalistic follow-up study.
    Baloush-Kleinman V; Levine SZ; Roe D; Shnitt D; Weizman A; Poyurovsky M
    Schizophr Res; 2011 Aug; 130(1-3):176-81. PubMed ID: 21636254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.